Systematic analysis of the varied designs of 819 therapeutic antibodies and Fc fusion proteins assigned international nonproprietary names
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic analysis of the varied designs of 819 therapeutic antibodies and Fc fusion proteins assigned international nonproprietary names
Authors
Keywords
-
Journal
mAbs
Volume 14, Issue 1, Pages -
Publisher
Informa UK Limited
Online
2022-09-16
DOI
10.1080/19420862.2022.2123299
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The evolution of bispecific antibodies
- (2022) Nimish Gera EXPERT OPINION ON BIOLOGICAL THERAPY
- International nonproprietary names for monoclonal antibodies: an evolving nomenclature system
- (2022) Sofia S. Guimaraes Koch et al. mAbs
- Antibody markup language (AbML) — a notation language for antibody-based drug formats and software for creating and rendering AbML (abYdraw)
- (2022) James Sweet-Jones et al. mAbs
- Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
- (2021) Hertzel C. Gerstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- New INN nomenclature for monoclonal antibodies
- (2021) Raffaella Balocco et al. LANCET
- NCATS Inxight Drugs: a comprehensive and curated portal for translational research
- (2021) Vishal B Siramshetty et al. NUCLEIC ACIDS RESEARCH
- R409K mutation prevents acid-induced aggregation of human IgG4
- (2020) Hiroshi Namisaki et al. PLoS One
- Format and geometries matter: Structure-based design defines the functionality of bispecific antibodies
- (2020) Steffen Dickopf et al. Computational and Structural Biotechnology Journal
- L445P mutation on heavy chain stabilizes IgG4 under acidic conditions
- (2019) Chang-Ai Xu et al. mAbs
- Bispecific antibodies: a mechanistic review of the pipeline
- (2019) Aran F. Labrijn et al. NATURE REVIEWS DRUG DISCOVERY
- Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life
- (2019) Kevin O. Saunders Frontiers in Immunology
- Thera-SAbDab: the Therapeutic Structural Antibody Database
- (2019) Matthew I J Raybould et al. NUCLEIC ACIDS RESEARCH
- Engineering of Fc Fragments with Optimized Physicochemical Properties Implying Improvement of Clinical Potentials for Fc-Based Therapeutics
- (2018) Chunpeng Yang et al. Frontiers in Immunology
- Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans
- (2018) Peter Ulrichts et al. JOURNAL OF CLINICAL INVESTIGATION
- The making of bispecific antibodies
- (2017) Ulrich Brinkmann et al. mAbs
- Changes to International Nonproprietary Names for antibody therapeutics 2017 and beyond: of mice, men and more
- (2017) Paul W. H. I. Parren et al. mAbs
- Current progress in innovative engineered antibodies
- (2017) William R. Strohl Protein & Cell
- IgG Fc engineering to modulate antibody effector functions
- (2017) Xinhua Wang et al. Protein & Cell
- The ChEMBL database in 2017
- (2016) Anna Gaulton et al. NUCLEIC ACIDS RESEARCH
- Utilizing the BiTE (bispecific T-cell engager) platform for immunotherapy of cancer
- (2015) Julia Stieglmaier et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- The INNs and outs of antibody nonproprietary names
- (2015) Tim D. Jones et al. mAbs
- Targeting FcRn for the modulation of antibody dynamics
- (2015) E. Sally Ward et al. MOLECULAR IMMUNOLOGY
- KEGG as a reference resource for gene and protein annotation
- (2015) Minoru Kanehisa et al. NUCLEIC ACIDS RESEARCH
- Cell Contact-Dependent Priming and Fc Interaction with CD32+ Immune Cells Contribute to the TGN1412-Triggered Cytokine Response
- (2014) P. Bartholomaeus et al. JOURNAL OF IMMUNOLOGY
- Afucosylated Antibodies Increase Activation of Fc RIIIa-Dependent Signaling Components to Intensify Processes Promoting ADCC
- (2014) S. D. Liu et al. Cancer Immunology Research
- SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML
- (2013) M. S. Kung Sutherland et al. BLOOD
- Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange
- (2013) A. F. Labrijn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Generating Bispecific Human IgG1 and IgG2 Antibodies from Any Antibody Pair
- (2012) Pavel Strop et al. JOURNAL OF MOLECULAR BIOLOGY
- Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma
- (2011) P. A. Moore et al. BLOOD
- Species-Specific Determinants in the IgG CH3 Domain Enable Fab-Arm Exchange by Affecting the Noncovalent CH3-CH3 Interaction Strength
- (2011) A. F. Labrijn et al. JOURNAL OF IMMUNOLOGY
- Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies
- (2011) W. Schaefer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
- (2008) Jagath R Junutula et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started